Total Payments
$816,276
2024 Payments
$85,046
Companies
64
Transactions
1,483
Medicare Patients
20,899
Medicare Billing
$1.0M
Payment Breakdown by Category
Other$671,806 (82.3%)
Travel$96,506 (11.8%)
Food & Beverage$34,550 (4.2%)
Consulting$13,355 (1.6%)
Education$59.63 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $659,886 | 284 | 80.8% |
| Travel and Lodging | $96,506 | 254 | 11.8% |
| Food and Beverage | $34,550 | 926 | 4.2% |
| Consulting Fee | $13,355 | 8 | 1.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $11,920 | 3 | 1.5% |
| Education | $59.63 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $236,981 | 233 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $191,557 | 229 | $0 (2023) |
| Lilly USA, LLC | $131,197 | 151 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $71,514 | 129 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $65,080 | 79 | $0 (2024) |
| Boston Scientific Corporation | $41,187 | 135 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $35,555 | 49 | $0 (2019) |
| Esperion Therapeutics, Inc. | $23,498 | 22 | $0 (2022) |
| Abbott Laboratories | $4,649 | 58 | $0 (2024) |
| Merck Sharp & Dohme LLC | $3,194 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $85,046 | 189 | Boehringer Ingelheim Pharmaceuticals, Inc. ($29,881) |
| 2023 | $75,773 | 163 | Boehringer Ingelheim Pharmaceuticals, Inc. ($34,022) |
| 2022 | $49,842 | 118 | Boehringer Ingelheim Pharmaceuticals, Inc. ($27,122) |
| 2021 | $61,805 | 98 | Boehringer Ingelheim Pharmaceuticals, Inc. ($28,991) |
| 2020 | $81,039 | 121 | AstraZeneca Pharmaceuticals LP ($21,689) |
| 2019 | $175,046 | 302 | Lilly USA, LLC ($46,188) |
| 2018 | $98,368 | 188 | Boehringer Ingelheim Pharmaceuticals, Inc. ($37,853) |
| 2017 | $189,358 | 304 | Novartis Pharmaceuticals Corporation ($105,261) |
All Payment Transactions
1,483 individual payment records from CMS Open Payments — Page 1 of 60
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | CORDIS US CORP. | Mynx Venous VCD (Device) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,075.00 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.61 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/11/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.84 | General |
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,450.00 | General |
| Category: DIABETES | ||||||
| 11/21/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: WATCHMAN_IC | ||||||
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $979.22 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $119.66 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $19.40 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Cardio-renal | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,450.00 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $6.03 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $5.70 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Travel and Lodging | In-kind items and services | $941.59 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/07/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $102.60 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 46 | 4,453 | 11,071 | $1.4M | $209,384 |
| 2022 | 43 | 4,018 | 9,694 | $1.3M | $194,113 |
| 2021 | 52 | 5,925 | 13,611 | $1.9M | $295,515 |
| 2020 | 51 | 6,503 | 13,901 | $2.1M | $347,618 |
Total Patients
20,899
Total Services
48,277
Medicare Billing
$1.0M
Procedure Codes
204
All Medicare Procedures & Services
204 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 412 | 809 | $349,241 | $54,681 | 15.7% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 56 | 57 | $74,328 | $14,518 | 19.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 166 | 240 | $83,480 | $12,342 | 14.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 101 | 101 | $39,592 | $11,795 | 29.8% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 20 | 28 | $66,885 | $11,035 | 16.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 73 | 75 | $35,775 | $9,540 | 26.7% |
| 36252 | Insertion of tube into first order main and accessory arteries of both kidneys for imaging with review by radiologist | Facility | 2023 | 48 | 48 | $223,008 | $8,131 | 3.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 83 | $21,165 | $7,677 | 36.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 40 | 160 | $21,174 | $7,652 | 36.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 72 | 131 | $22,270 | $7,487 | 33.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 42 | 43 | $44,720 | $7,021 | 15.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 107 | 108 | $29,484 | $5,254 | 17.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 54 | $13,230 | $4,298 | 32.5% |
| 71275 | Ct scan of blood vessels of chest with contrast | Office | 2023 | 34 | 34 | $30,770 | $4,208 | 13.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 401 | 404 | $72,316 | $4,142 | 5.7% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 154 | 184 | $10,295 | $3,196 | 31.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 417 | 527 | $21,080 | $2,854 | 13.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 42 | 76 | $10,380 | $2,788 | 26.9% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 417 | 527 | $22,661 | $2,256 | 10.0% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 139 | 161 | $29,624 | $2,174 | 7.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 16 | $5,472 | $2,164 | 39.5% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 139 | 162 | $30,780 | $1,784 | 5.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 134 | 201 | $4,020 | $1,681 | 41.8% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 76 | 76 | $13,224 | $1,566 | 11.8% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 165 | 199 | $49,750 | $1,526 | 3.1% |
About Dr. Patrick Simpson, MD
Dr. Patrick Simpson, MD is a Cardiovascular Disease healthcare provider based in Pinehurst, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841234887.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Simpson, MD has received a total of $816,276 in payments from pharmaceutical and medical device companies, with $85,046 received in 2024. These payments were reported across 1,483 transactions from 64 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($659,886).
As a Medicare-enrolled provider, Simpson has provided services to 20,899 Medicare beneficiaries, totaling 48,277 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 204 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Pinehurst, NC
- Active Since 06/16/2006
- Last Updated 01/23/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1841234887
Products in Payments
- JARDIANCE (Drug) $345,101
- ENTRESTO (Drug) $191,544
- PRALUENT (Drug) $64,849
- BRILINTA (Drug) $54,915
- WATCHMAN Access System (Device) $35,368
- PRALUENT ALIROCUMAB INJECTION (Biological) $25,098
- NEXLIZET (Drug) $23,491
- FARXIGA (Drug) $16,473
- TRULICITY (Drug) $12,160
- PRALUENT (Biological) $10,456
- WATCHMAN FLX (Device) $4,859
- VERQUVO (Drug) $3,194
- Xience V coronary stent system (Device) $1,551
- Rybelsus (Drug) $1,290
- ELIQUIS (Drug) $1,121
- Impella (Device) $1,000
- BPRO BT AMBULATORY BLOOD PRESSURE MONITORING SYSTEM (Device) $934.82
- XARELTO (Drug) $693.02
- CardioMEMS HF System (Device) $548.36
- AMPLATZER Occluders (Device) $541.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Pinehurst
Herbert Strunk, Do, DO
Cardiovascular Disease — Payments: $15,303
Cardiovascular Disease $15,303
Keith Davis, Md, MD
Cardiovascular Disease — Payments: $11,216
Cardiovascular Disease $11,216
Peter Vassallo, M.d, M.D
Cardiovascular Disease — Payments: $10,610
Cardiovascular Disease $10,610
Ker Boyce, Md, MD
Cardiovascular Disease — Payments: $10,577
Cardiovascular Disease $10,577
David Cowherd, Md, MD
Cardiovascular Disease — Payments: $7,578
Cardiovascular Disease $7,578
Joseph Parrish, Md, MD
Cardiovascular Disease — Payments: $3,421
Cardiovascular Disease $3,421